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Background: Questionnaire and spirometry were applied to post-tuberculosis indigenous and
non-indigenous individuals from Dourados, Brazil, to investigate the prevalence of chronic
respiratory symptoms and pulmonary dysfunction.
Methods: This was a cross-sectional study in cured tuberculosis individuals as reported in
the  National System on Reportable Diseases (SINAN) from 2002 to 2012.
Results: One hundred and twenty individuals were included in the study and the prevalence
of  chronic respiratory symptoms was 45% (95% CI, 34–59%). Respiratory symptoms included
cough (28%), sputum (23%), wheezing (22%) and dyspnea (8%). These symptoms were associ-
ated  with alcoholism, AOR: 3.1 (1.2–8.4); less than 4 years of schooling, AOR: 5.0 (1.4–17.7); and
previous pulmonary diseases, AOR: 5.4 (1.7–17.3). Forty-one percent (95% CI, 29–56) had pul-
monary disorders, of which the most prevalent were obstructive disorders (49%), followed
by  obstructive disorder with reduced forced vital capacity disorders (46%) and restrictive
disorders (5%). The lifestyle difference could not explain differences in chronic symptoms
and/or the prevalence of pulmonary dysfunction.
Conclusion: The high prevalence of chronic respiratory symptoms and pulmonary dysfunc-tion  in post-tuberculosis patients indicates a need for further interventions to reduce social
vulnerability of patients successfully treated for tuberculosis.
© 2015 Elsevier Editora Ltda. All rights reserved.∗ Corresponding author at: Faculdade de Ciências da Saúde, Universidad
Dourados, Mato Grosso do Sul, 79804-970, Brazil.
E-mail address: juliocroda@ufgd.edu.br (J. Croda).
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ntroduction
uberculosis (TB) is a chronic disease with one of the highest
orbidity and mortality rates worldwide. Certain groups, such
s indigenous populations, may be more  susceptible to devel-
ping the disease.1–3 The incidence of TB among indigenous
eople is consistently higher than in the general population.
etween January 2002 and December 2008, the mean of annual
B notiﬁcations in the indigenous population of Dourados was
60 per 100,000 inhabitants compared to only 25 per 100,000
nhabitants in non-indigenous populations.4–6 Among treated
nd cured TB patients, some may develop respiratory seque-
ae characterized by chronic respiratory symptoms, including
ough, sputum, and dyspnea. These sequelae may persist even
n individuals who  have been properly treated for TB and
hould not be overlooked as they have a negative impact on
he individual’s quality of life.7
There is no consensus on which disorder is the most preva-
ent in individuals with TB sequelae.7–12 Population-based
tudies are needed to investigate the persistence of chronic
ymptoms and changes in lung function. In addition, indige-
ous populations have different immune responses and risk
actors associated with TB compared with non-indigenous
opulations.13,14 Thus, further studies are needed to clarify
hether there are differences with regard to the prevalence of
hese changes between these two populations. In this sense,
he objective of this study was to investigate the prevalence
f chronic respiratory symptoms and pulmonary dysfunc-
ion in post-tuberculosis individuals and to compare these
esults between indigenous and non-indigenous populations
f Dourados-MS.
aterial  and  methods
tudy  design  and  inclusion  and  exclusion  criteria
his was a cross-sectional population-based study of indige-
ous and non-indigenous individuals with a history of TB
s reported by the National System on Reportable Diseases
SINAN) from January 2002 to December 2012 in Dourados-MS.
e included individuals with notiﬁcations of TB to the SINAN
iagnosed between 2002 and 2012. We excluded individuals
nder 18 or over 65 years of age, prisoners, residents of other
unicipalities, and patients with changes in diagnosis or with
eurological disorders.
Data collection was conducted by visiting each partic-
pant’s home from November 2013 to October 2014. The
uestionnaire was administered to the participants in order
o collect sociodemographic, clinical and epidemiological vari-
bles that could be associated with the development of
ulmonary changes post-tuberculosis such as persistence
f respiratory symptoms and pulmonary function. The fol-
owing variables were considered: gender, age, educational
evel, nationality, race, occupation, marital status, alcohol use,
moking, passive smoking, previous pulmonary diseases (pul-
onary emphysema, bronchitis, and pleural effusion), work
n a dusty and/or smoky environment, wood-stove use, and
ersistence of respiratory symptoms such as cough, phlegm,5;1 9(5):492–497 493
sputum, wheezing, and dyspnea after successful TB treat-
ment.
Spirometry
Evaluations of pulmonary function were performed by
spirometry using a portable spirometer Koko Spirometer
(manufactured by nSpire Health, Inc, Lefthand Circle, Long-
mont, USA, Koko PFT Software, Series No. 1329K3A39) that
allowed for the new Brazilian standards for calculating the the-
oretical value of adults according to the new reference values
for forced spirometry in Brazilian populations to be used.12 We
evaluated the forced expiratory volume in one second (FEV1),
the forced vital capacity (FVC), ratio of the forced expiratory
volume in one second to the forced vital capacity (FEV1/FVC),
and the forced expiratory ﬂow between 25 and 75% (FEF25–75%).
The tests consisted of pre- and post-bronchodilator phases,
the latter obtained 15 min  after the administration of 400 g
of salbutamol.
Patients were classiﬁed in accordance to the Guidelines for
Pulmonary Function Tests of the Brazilian Society of Pneu-
mology and Tisiology. Spirometry was considered as normal
when the FVC, FEV1 and FEV1/FVC were equal to or greater
than 80% of the predicted value. Obstructive disorder was con-
sidered when the FEV1/FVC ratio was below 80% and FEV1 was
less than 80% of the predicted value. A patient was classi-
ﬁed with a restrictive disorder when the FEV1/FVC ratio was
less than 80% and FVC was below 80% of the predicted value.
Obstructive disorder with reduced forced vital capacity was
considered when the difference between FVC and FEV1 for the
pre-bronchodilator phase was less than or equal to 12%.15
Statistical  analysis
All clinical data were entered in duplicate into the elec-
tronic database EpiData, version 3.1 (The EpiData Association,
Odense, Denmark), and SAS version 9.2 (SAS Institute, Cary,
NC) was used to analyze the univariate and multivariate mod-
els associated with chronic symptoms. Dichotomized and
categorical data were analyzed with the chi-squared test or
Fisher’s exact test. For continuous variables, the t-test or
analysis of variance (ANOVA) were utilized. Univariate anal-
yses were performed to verify the associations between the
dependent and independent variables, and those achieving
a pre-speciﬁed level of signiﬁcance (p < 0.20) were included
in the multivariate analysis. Logistic regression analysis was
used to estimate the adjusted odds ratios.
Ethical  considerations
All eligible individuals were informed about the study, and the
questionnaire and spirometry were performed after receiv-
ing a written approval in the informed consent. Informed
consent forms in the Guaraní language were used for the
indigenous population. The consent forms were read to the
illiterate participants and they provided their consent using
their ﬁngerprint. The project was approved by the Research
Ethics Committee of the Federal University of Grande Doura-
dos and by the National Research Ethics Committee of the
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Patients repo rted 
to SINAN: 2002  
to 2012: 800
Excluded 
patients: 325
Age <18 or
>65: 200
Eligible 
patients: 475
Diagnosis 
change: 4
Neurological 
disorders: 6
Deprived of 
liberty: 74
Residents in 
other 
municipalities: 41
Losses: 314
Patients found: 
161
Change of 
address:  20
Death s:  7
Patients who 
refused  to  
participate in 
the study: 2
Patients 
included in 
the study: 65
Patient s who 
underwent 
spirometry: 
50
Patients who  
did not perform 
spirometry: 15
Patients who 
refused to 
participate in 
the stu dy: 38
Patients 
included in 
the stu dy: 56
Patient s who 
underwent 
spirometry: 
50
Patients who 
did not perform 
spirometry: 6
Indigenous: 67 Non-indigenous: 94
Change of 
address: 1 46
Death s: 11
Patients with 
incomple te 
address or 
phone in the 
notification: 
130 
Indigenous: 
27
Non-indigenous: 287
y of tFig. 1 – Flow chart of individuals with a histor
National Health Council (CAAE: 05532912.8.0000.5160/Num-
ber: 193.877).
Results
During the study period, 800 individuals were diagnosed with
tuberculosis and reported to the SINAN. Of those, 325 were
excluded (Fig. 1). We  were not able to interview 318 of the
475 individuals included in this study because 166 changed
their home address, 18 died, and 130 could not be found due
to incorrect address and phone contact information. We  con-
tacted 161 individuals, and 25% refused to participate in the
study. The ﬁnal sample of 121 participants was divided into
two groups: indigenous (n = 61) and non-indigenous (n = 60)
(Fig. 1). Twenty-one individuals did not reproduce acceptable
spirometry curves, including two who  presented nausea, four
due to missing teeth, 10 failed to perform the maneuvers
because of difﬁculties in understanding the commands, and
ﬁve were unable to undergo spirometry due to severe dyspnea.
Table 1 shows the sociodemographic characteristics of the
indigenous and non-indigenous individuals with a history of
tuberculosis. Among the indigenous participants, 57% were
male, and 87% had less than four years of schooling. In the
non-indigenous group, 47% were male, and 78% had less
than four years of schooling; this same group also included
more  individuals who  used alcohol, illicit drugs, and smoked.
Non-indigenous individuals had more  current history of spu-
tum production than indigenous (p = 0.05). Cough, wheezing
and dyspnea, as well as the spirometric values, were similar
between the ethnic groups considered (Table 1).
The prevalence of respiratory symptoms was 45% (95% CI,
34–59%) and included cough (28%), sputum (23%), wheezing
(22%), and dyspnea (8%). Compared with asymptomatic indi-
viduals, post-tuberculosis individuals with symptoms were
more likely to have less then four years of schooling (93% ver-
sus 74%, p < 0.01), work in dusty environment (44% versus 25%,
p = 0.03), and to have had previous pulmonary diseases (25%
versus 8%, p < 0.01) The majority of the individuals who had
symptoms had abnormal spirometry when compared to indi-
viduals with no symptoms (65% versus 35%, p < 0.01) (Table 2).uberculosis in Dourados, Mato Grosso do Sul.
In the multivariate model, the following variables were asso-
ciated with the presence of symptoms: less than four years of
schooling, AOR: 5.0 (1.4–17.7); alcohol abuse, AOR: 3.1 (1.2–8.3);
and previous pulmonary diseases, AOR: 5.4 (1.7–17.4) (Table 3).
Among the participants, 41% (95% CI, 29–56) had pulmonary
disorders, of which the most prevalent were obstructive dis-
orders (49%), followed by obstructive disorder with reduced
forced vital capacity disorders (46%), and restrictive disorders
(5%). Eighteen individuals had moderate pulmonary dysfunc-
tion, and only 1 (6%) had been diagnosed with lung disease
and were under medical care.
Discussion
Few studies have evaluated the permanence of post-
tuberculosis respiratory symptoms, which reinforces the
importance of this research, considering the negative impact
and inﬂuence on the quality of life of individuals affected by
these changes in lung function.7,9,10,16
In our population-based study, we observed the presence
of chronic symptoms such as cough, sputum, dyspnea, and
wheezing in 45% of subjects even after the completion of treat-
ment and cure of TB. This persistence of respiratory symptoms
was also found in a study of adult patients treated in the out-
patient TB clinic of a university hospital in which 72% of the
56 patients had chronic symptoms similar to those found in
this study.9
Among the prevalent post-tuberculosis symptoms, cough
and sputum have been reported, and according to a study in
the Institute of Pulmonology, these symptoms were present in
80% of patients followed. Dyspnea was also mentioned by 45%
of the patients.17 Sputum production has been correlated with
the residual lung damage, as reported by Hnizdo et al.18 Even
in individuals who properly treated for tuberculosis, there is
persistence of symptoms; recent research has shown that 3/5
of the population studied showed persistent post-tuberculosis
7respiratory symptoms.
Delays in the diagnosis and initiation of TB treatment
can lead to increased injury to the lung parenchyma, and
this damage worsens with the duration of disease, causing
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Table 1 – Sociodemographic characteristics, chronic respiratory symptoms and spirometry parameters of indigenous and
non-indigenous individuals with a history of tuberculosis in Dourados (n = 121).
Variables Race
Number  (percentage)
p  value
Indigenous (n = 61) Non-indigenous (n = 60)
Sex, male 35 (57) 28 (47) 0.24
Age, years, mean ± SDa 38 ± 15 42 ± 15 0.20
Marital status, single 9 (15) 31 (52) <0.01
Less than 4 years of schooling 53 (87) 47 (78) 0.21
BMI, mean ± SDa 25 ± 4 24  ± 5 0.27
Current smoker 13  (21) 30 (50) <0.01
Passive smoker 6 (10) 13 (22) 0.07
Drug use 1 (2) 12 (25) <0.01
Alcoholism 6 (10) 18 (30) <0.01
Work in dusty environment 9 (13) 31 (52) <0.01
Work in smoky environment 7 (12) 6 (10) 0.74
Previous pulmonary diseasesb 5 (8) 14 (24) 0.02
Symptoms 24 (20) 31 (26) 0.17
Cough 18 (15) 24 (20) 0.23
Sputum production 14 (12) 24 (20) 0.05
Wheezing 14 (12) 17 (14) 0.50
Dyspnea grade 2 1(1) 5 (5) 0.11c
Dyspnea grade 3 3 (3) 0 (0) 0.24c
Dyspnea grade 4 0 (0) 1 (1) 0.49c
Spirometry parameters
FEV1/FVC × 100 86% 89% 0.40
FEV1 85% 87% 0.62
FVC 89% 86% 0.67
FEF25–75% 82% 80% 0.57
Pattern of spirometry 0.35
Normal 29 (58) 30 (60)
Obstructive 8 (16) 12 (24)
Obstructive disorder with reduced forced vital capacity 11 (22) 8 (16)
Restrictive 2 (4) 0 (0)
BMI, Body Mass Index; FVC, forced vital capacity; FEV1, forced expiratory volume in the ﬁrst second; FEV1/FVC, ratio of forced expiratory volume
in the ﬁrst second and forced vital capacity; FEF 25–75%, forced expiratory ﬂow between 25 and 75%.
a Standard deviation.
b effusi
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tPrevious pulmonary diseases: bronchitis, emphysema and pleural 
c Fisher’s exact test.
ersistent respiratory symptoms and lung dysfunction.11,18–20
he results of this study indicate that some factors can be
ritical to the presence of chronic respiratory symptoms
n individuals with a history of tuberculosis; among these
actors, there is an emphasis on education, alcohol use, and
revious respiratory diseases.2,21 Low level of education is
elated to low socioeconomic status, and this is a recognized
isk factor for TB. In addition, the social condition of the
ndividual can lead to less access to health services and,
onsequently, to a diagnosis of tuberculosis. Alcohol con-
umption can also be associated with a late diagnosis, and
ocioeconomic conditions in both delayed situations expose
he individual to longer disease duration and, therefore, an
ncreased likelihood of pulmonary sequelae.2,21
Using diagnostic services, a study in Dourados-MS noted
hat 75% of indigenous and 65% of non-indigenous individuals
ought treatment at the onset of symptoms. However, most
atients reported a diagnostic delay; 46% of indigenous and
4% of non-indigenous patients need at least three (3) medical
onsultations to receive a diagnosis of TB, which took more
han ﬁve weeks. Therefore, these patients spent more  timeon.
exposed to the disease and were more  susceptible to post-
pulmonary tuberculosis sequelae.21
Another study involving an indigenous population of
Dourados-MS concluded that this population had greater
access to diagnostic tests and treatment compared with the
non-indigenous population. The diagnosis and consequent
early treatment in the indigenous population compared with
the non-indigenous population might explain why there were
no differences in the length of symptoms or changes in pul-
monary function between the populations studied, even in
the face of the different living habits, cultural barriers, and
the lower level of education and socioeconomic status of the
indigenous population.5,21
Among the individuals who underwent spirometry in
our study, 41% had pulmonary function changes: the most
prevalent were obstructive disorders (49%), followed by
obstructive disorder with reduced forced vital capacity (46%)
and restrictive disorders (5%). It remains unclear which
respiratory disorder is most prevalent in post-tuberculosis
sequelae due to the small number of studies conducted.
Ramos et al., Santa Cruz et al. and Di Naso et al. in their
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Table 2 – Differences among patients with a history of tuberculosis stratiﬁed by presence of symptoms in Dourados
(n = 121).
Variables Symptoms
Number  (percentage)
p  value
Symptoms
(n = 55)
Non-symptoms
(n  = 66)
Clinical and epidemiological
Sex, male 22 (40) 41 (62) 0.01
Race, indigenous 24 (44) 31 (56) 0.17
Marital Status, single 20  (37) 21 (32) 0.53
Age, years, mean ± SDa 43 ± 14 38  ± 15 0.11
Less than 4 years of schooling 51 (93) 49 (74) <0.01
Current smoker 22 (40) 21 (32) 0.35
Passive smoker 9 (17) 10 (15) 0.85
Drug use 10  (18) 6 (9) 0.14
Alcoholism 15 (27) 9 (14) 0.06
Work in dusty environment 24 (44) 16 (25) 0.03
Work in smoky environment 8 (15) 5 (8) 0.24
Cook with a wood stove 16 (30) 15 (24) 0.48
Previous pulmonary diseasesb 14 (25) 5 (8) <0.01
Pattern of spirometry <0.01
Normal 14 (35) 45 (75)
Obstructive 13 (33) 7 (12)
Obstructive disorder with reduced forced vital capacity 11 (27) 8 (13)
Restrictive 2 (5) 0 (0)
a Standard deviation.
b Previous pulmonary diseases: bronchitis, emphysema and pleural effusion.
Table 3 – Risk factors associated with respiratory symptoms in individuals with a history of tuberculosis (n = 121).
Variables Crude OR (95% CI) Adjusted OR (95% CI)
Race, indigenous 1.64 (0.80–3.39)
Age, per year 0.98 (0.95–1.00)
BMI 0.96 (0.88–1.05)
Sex, male 2.46 (1.18–5.12)
Marital status, single 1.22 (0.57–2.60)
Less than 4 year of schooling 4.42 (1.39–14.07) 5.01 (1.42–17.66)
Smoking 1.42 (0.68–3.02)
Passive smoking 1.09 (0.41–2.92)
Drug use 2.22 (0.75–6.56)
Alcoholism 2.37 (0.94–5.95) 3.10 (1.16–8.30)
Previous pulmonary diseasesa 4.09 (1.37–12.25) 5.42 (1.69–17.34)
Work in dusty environment 2.37 (1.09–5.15)
Work in smoky environment 2.01 (0.61–6.58)
Cook with a wood stove 1.34 (0.59–3.06)
effusiBMI, Body Mass Index; OR, odds ratio.
a Previous pulmonary diseases: bronchitis, emphysema and pleural 
respective studies evaluated the association between TB
and altered pulmonary function, and there was no common
consensus on which disorder was the most prevalent as a
sequel.9,19,20
Our study had some limitations, such as a number of
refusals to participate by individuals who thought they were
cured and had no symptoms and the difﬁculty of ﬁnding
the households due to the large number of records with
nonexistent phone numbers and addresses. Furthermore, 8%
of the indigenous and 24% of the non-indigenous individuals
had previous pulmonary diseases and therefore could have
symptoms and functional changes attributed to the under-
lying disease and not related to TB sequelae. Not all patientson.
underwent chest X-ray because the exam was not included
in the study objectives.
It is important to emphasize that 17% of the individuals
included in the study were unable to complete the spirometry
due to difﬁculty in understanding the guidelines, dental issues
and/or chronic respiratory symptoms. Among patients who
did not complete the survey, 66% had a low level of education
and low socioeconomic status, which most likely hindered
their comprehension of the guidelines for performing the
required expiratory maneuvers. Most of these individuals
were indigenous, and in our opinion, they need further atten-
tion regarding their symptoms for the diagnosis of possible
pulmonary sequelae.
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management and prevention of chronic obstructive
pulmonary disease – update 2014. Available from: http://www.b r a z j i n f e c t d i s .
For the individuals who could not perform the spirometry
est, possible pulmonary sequelae could be diagnosed by the
espiratory symptoms presented by these individuals. Accord-
ng to Global Obstructive Lung Disease (GOLD, 2014), chronic
ymptoms should be considered, as they may indicate the
everity of pulmonary sequelae.22
The high prevalence of chronic respiratory symptoms
nd pulmonary dysfunction in post-tuberculosis patients
ndicates a need for further interventions to reduce social vul-
erability in patients with post-tuberculosis.
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